Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
However, not all companies with momentum are long-term winners, and many investors have lost money by following short-term trends. Keeping that in mind, here are three stocks that are likely overheated and some you should look into instead.
Texas Instruments (TXN)
One-Month Return: +39.4%
Headquartered in Dallas, Texas since the 1950s, Texas Instruments (NASDAQ:TXN) is the world’s largest producer of analog semiconductors.
Why Does TXN Give Us Pause?
- Scale is a double-edged sword because it limits the company’s growth potential compared to its smaller competitors, as reflected in its below-average annual revenue increases of 3.6% for the last five years
- Demand will likely be soft over the next 12 months as Wall Street’s estimates imply tepid growth of 9.3%
- Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 10.8 percentage points
At $263.04 per share, Texas Instruments trades at 34.4x forward P/E. To fully understand why you should be careful with TXN, check out our full research report (it’s free).
Arrow Electronics (ARW)
One-Month Return: +29.7%
Founded as a single retail store, Arrow Electronics (NYSE:ARW) provides electronic components and enterprise computing solutions to businesses globally.
Why Do We Avoid ARW?
- Sales tumbled by 3.5% annually over the last two years, showing market trends are working against its favor during this cycle
- Sales were less profitable over the last two years as its earnings per share fell by 19.7% annually, worse than its revenue declines
- Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
Arrow Electronics’s stock price of $181.43 implies a valuation ratio of 12.9x forward P/E. Read our free research report to see why you should think twice about including ARW in your portfolio.
agilon health (AGL)
One-Month Return: +157%
Transforming how doctors care for seniors by shifting financial incentives from volume to outcomes, agilon health (NYSE:AGL) provides a platform that helps primary care physicians transition to value-based care models for Medicare patients through long-term partnerships and global capitation arrangements.
Why Are We Cautious About AGL?
- Sales are projected to tank by 8% over the next 12 months as demand evaporates
- Efficiency has decreased over the last five years as its adjusted operating margin fell by 3.6 percentage points
- Cash-burning tendencies make us wonder if it can sustainably generate shareholder value
agilon health is trading at $28.27 per share, or 0.1x forward price-to-sales. Dive into our free research report to see why there are better opportunities than AGL.
Stocks We Like More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.